Monoclonal antibodies produced by new cell lines hope to improve drugs
Many biopharmaceutical companies look to produce biosimilars soon, since the patents on the original mAb expire over the next few years...
List view / Grid view
Many biopharmaceutical companies look to produce biosimilars soon, since the patents on the original mAb expire over the next few years...
A group of scientists have zeroed in on a new defence against HIV-1, the virus that causes AIDS...
The components of the immune system that trigger allergic reactions may also help protect the skin against cancer, suggest new findings...
AlphaLISA® provides a robust assay that facilitates the design and development of antibody therapeutics.
Antibody mAb806 may be useful in treating aggressive forms of glioblastoma multiform...
Your comprehensive guide to multiplex and single protein detection...
Research scientists have solved a major problem in chemistry and drug development by using droplet-sized 'mini-ecosystems to quickly see if a molecule can function as a potential therapeutic...
The researchers identified that BAFF to have anti-inflammatory properties, which has a positive effect on plaque size and atherosclerosis...
15 June 2018 | By IntelliCyt
The Intellicyt Mouse IgG Type and Titer Kit is a high throughput, multiplexed assay kit that enables analyses of isotype, titer and cell health in a single assay...
Analyse isotype titer and cell health in one assay...
Study uncovers new potential therapeutic approach for a number of diseases linked to inflammation, including atherosclerosis, aortic stenosis and hepatic steatosis...
For most people, traditional High-Throughput Screening (HTS) represents large automation rigs and large libraries of small molecules screened against drug targets, however, the development of biological therapeutics has been gaining considerable pace for many reasons.
The demand for new therapeutics is driving efforts to discover novel antibodies and harness their power in both biologics and adoptive cell therapy areas.
Japan-US research collaboration has found that red blood cells that express a novel gene may contribute to adult newt limb regeneration.